<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00375687</url>
  </required_header>
  <id_info>
    <org_study_id>KMU-Urol1</org_study_id>
    <nct_id>NCT00375687</nct_id>
  </id_info>
  <brief_title>Investigation of Early Hormonotherapy Efficacy of Prostate Cancer</brief_title>
  <official_title>Investigation of Early Hormonotherapy Efficacy of High Risk Patients for Progression of Prostate Cancer After Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaunas University of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaunas University of Medicine</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether early hormonotherapy is effective in the
      treatment of high risk prostate cancer patients after radical prostatectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary purpose of this study is to evaluate the hypothesis, that early administration of
      adjuvant hormonotherapy (triptorelin) can prolong survival data for high risk patients.
      Control group (randomised study) will be treated with hormonotherapy, when PSA recidive
      appear (on demand treatment). Secondary purposes will be to compare PSA dinamics and quality
      of life data in the groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2005</start_date>
  <completion_date>January 2020</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>PSA dinamics</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
  </secondary_outcome>
  <enrollment>61</enrollment>
  <condition>Prostate Cancer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triptorelin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preoperative PSA&gt;20ng/ml

          -  postoperative PSA &gt;0.2 ng/ml

          -  Gleason &gt; 7

          -  pT3b

          -  signated infomed consent

        Exclusion Criteria:

          -  neoadjuvant hormonaltherapy before RP

          -  R1 RP

          -  N+ RP

          -  unstable cncomitant conditions
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mindaugas Jievaltas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology dep. of Kaunas University of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mindaugas Jievaltas, PhD</last_name>
    <phone>+37068730659</phone>
    <email>minjiev@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Urology dep. of Kaunas University of Medicine</name>
      <address>
        <city>Kaunas</city>
        <zip>50009</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mindaugas Jievaltas, MD, PhD</last_name>
      <phone>+37068730659</phone>
      <email>minjiev@Yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Mindaugas Jievaltas, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>November 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2006</study_first_submitted>
  <study_first_submitted_qc>September 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2006</study_first_posted>
  <last_update_submitted>September 12, 2006</last_update_submitted>
  <last_update_submitted_qc>September 12, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2006</last_update_posted>
  <keyword>Prostate cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triptorelin Pamoate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

